Core Scientific第四季度调整后每股亏损$(0.13) 超出$(0.08)预期,销售额为$94.92M 不及预期$99.92M

财报速递
02-27
Core Scientific(纳斯达克股票代码:CORZ)报告的季度每股亏损为$(0.13),比分析师一致预期的$(0.08)低62.5%。这比去年同期每股亏损$(0.51)增加了74.51%。公司报告的季度销售额为$94.92M,比分析师一致预期的$99.92M低5%。这比去年同期的$141.93M下降了33.12%。

以上内容来自Benzinga Earnings专栏,原文如下:

Core Scientific (NASDAQ:CORZ) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.08) by 62.5 percent. This is a 74.51 percent increase over losses of $(0.51) per share from the same period last year. The company reported quarterly sales of $94.92 million which missed the analyst consensus estimate of $99.92 million by 5.00 percent. This is a 33.12 percent decrease over sales of $141.93 million the same period last year.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10